Metasphere Labs Inc.
LABZF
$0.05
-$0.04-45.46%
OTC PK
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -24.21% | 141.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.21% | 99.89% | |||
| Operating Income | 15.93% | -144.21% | |||
| Income Before Tax | -33.99% | -91.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -33.99% | -91.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.99% | -91.46% | |||
| EBIT | 15.93% | -144.21% | |||
| EBITDA | 16.40% | -153.64% | |||
| EPS Basic | -26.14% | -101.32% | |||
| Normalized Basic EPS | 11.46% | -100.00% | |||
| EPS Diluted | 31.32% | -269.74% | |||
| Normalized Diluted EPS | 11.46% | -100.00% | |||
| Average Basic Shares Outstanding | 5.91% | -4.60% | |||
| Average Diluted Shares Outstanding | 5.91% | -4.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||